Summary & Overview
HCPCS K1002: Cranial Electrotherapy Stimulation System
HCPCS Level II code K1002 identifies a cranial electrotherapy stimulation (CES) system — a durable medical device that delivers low-level electrical stimulation to the cranium for therapeutic indications. The code matters nationally as payers and suppliers navigate coverage, reimbursement, and appropriate use of neuromodulation devices that may be used in behavioral health and pain management pathways. Key payers included in this analysis are Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare.
Readers will find a concise overview of what K1002 represents, how the device is typically supplied and used (outpatient settings and home use as a durable medical device), and an explanation of common operational considerations for billing and claims processing. The publication summarizes benchmark metrics where available, highlights relevant policy and coverage themes affecting CES device reimbursement, and outlines the clinical context in which CES systems are applied. Data not available in the input is noted where applicable. The intent is to inform billing managers, clinical program leads, and policy analysts about the code’s purpose, payer landscape, and the topics to consider when managing services tied to K1002.
Billing Code Overview
HCPCS Level II code K1002 represents a cranial electrotherapy stimulation (CES) system, any type. This billing code covers the device used to deliver low-level electrical stimulation to the cranium for therapeutic purposes.
-
Service type: Durable medical device therapy involving a cranial electrotherapy stimulation system
-
Typical site of service: Outpatient clinics, outpatient specialty centers, behavioral health clinics, and patient home use when supplied as a durable medical device
Clinical & Coding Specifications
Clinical Context
A typical patient is a 35–65-year-old adult presenting to an outpatient behavioral health clinic with persistent symptoms of generalized anxiety disorder, major depressive disorder with mild-to-moderate severity, or chronic insomnia who has had inadequate response or intolerance to first-line pharmacologic and psychotherapeutic treatments. The clinician (psychiatrist, neurologist, or pain medicine specialist) documents treatment history, obtains informed consent, and performs a brief baseline assessment including symptom severity scales (for example, PHQ-9, GAD-7, or Insomnia Severity Index). The cranial electrotherapy stimulation (CES) device is either applied in clinic as a single supervised session for acute symptom management or provided as a take-home device with training for daily home use. Typical workflow steps include: device selection and verification (K1002 describes a CES system), education on device operation and safety, documentation of baseline symptoms and contraindications (for example, implanted electronic devices, unstable seizure disorder), programming and electrode placement, supervised treatment session (usually 20–60 minutes) or device dispensing with documented training, and follow-up visits to assess efficacy and adverse effects. Billing uses HCPCS Level II code K1002 for the CES system; additional evaluation and management or psychotherapy CPT codes may be billed separately when medically appropriate and supported by documentation.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|